Home
Welcome
In conjunction with our Hospital partners, TTMI spearheads the integration of basic biomedical and clinical research focusing on Cancer, Genomics and Immunology to detect, diagnose and treat health conditions
Core Infrastructure
Project Highlights
- Ireland takes significant step towards strengthening collaboration with EATRIS TTMI and EATRIS-ERIC are pleased to announce the signing of an MoU to foster collaboration and coordination in promoting the benefits of Ireland’s potential membership in EATRIS-ERIC
- Building Engagements in Health Research Fund The BEHR Fund provides financial support and resources to catalyse partnerships between TTMI scientists and Trinity-affiliated clinicians, creating a dynamic environment for translational research.
- Translational Medicine Alliance Ireland (TMAI) TMAI is organised as a decentralised collaborative alliance of 10 Irish Universities that will catalyse the development of productive translational research collaborations under one umbrella to maximise the exploitation of complementary strengths and drive clinical innovations.
- €4.8M investment in Trinity COVID-19 Immunology Research hub The Trinity COVID-19 Immunology Research hub seeks to utilize its world-class immunology expertise to provide research-based solutions to tackle the COVID-19 pandemic
- €10.5M programme to develop next generation cell therapies for cancer Researchers at TTMI are part of a successful consortium to secure €6.8M government funding as part of a 3-year, €10.5M programme to develop next generation cell therapies for cancer.
- €7.2M programme to deliver next generation gene therapies for gastrointestinal cancer TTMI researchers are part of a successful consortiuma planning to invest €7.2 million in developing a better way to treat gastrointestinal cancer